Negative regulation of FcεRI signaling by FcγRII costimulation in human blood basophils

Journal of Allergy and Clinical Immunology

Volumn 106, Issue 2, 2000, Pages 337-348

  Kepley, Christopher L ^a   Cambier, John C ^b   Morel, Penelope A ^c   Lujan, Don ^a   Ortega, Enrique ^d   Wilson, Bridget S ^a   Oliver, Janet M ^a  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Allergy; Basophil; Fc receptors; Fc RI; Human; Mast cell; Signal transduction

Indexed keywords

FC RECEPTOR; IMMUNOGLOBULIN E RECEPTOR; PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE; RNA; SYNTHETIC PEPTIDE; CALCIUM; CROSS LINKING REAGENT; ENZYME PRECURSOR; INPPL1 PROTEIN, HUMAN; INTERLEUKIN 4; PROTEIN KINASE SYK; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE SHP 1; PTPN6 PROTEIN, HUMAN; SIGNAL PEPTIDE; SRC HOMOLOGY 2 (SH2) DOMAIN CONTAINING PHOSPHATASES; SRC HOMOLOGY-2 (SH2) DOMAIN-CONTAINING PHOSPHATASES;

ARTICLE; BASOPHIL; CALCIUM MOBILIZATION; CONTROLLED STUDY; CROSS LINKING; HISTAMINE RELEASE; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; MAST CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SOUTHERN BLOTTING; BIOSYNTHESIS; BLOOD; CHEMISTRY; DEGRANULATION; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; GENE TRANSLOCATION; GENETICS; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; SRC HOMOLOGY DOMAIN;

BASOPHILS; CALCIUM; CELL DEGRANULATION; CROSS-LINKING REAGENTS; DOWN-REGULATION; ENZYME PRECURSORS; HUMANS; INTERLEUKIN-4; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; PHOSPHORIC MONOESTER HYDROLASES; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; PROTEIN-TYROSINE-PHOSPHATASE; RECEPTORS, IGE; SHP1 PROTEIN TYROSINE PHOSPHATASE; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAINS; TRANSLOCATION, GENETIC;

EID: 0033624162     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2000.107931     Document Type: Article

References (51)

1. Antigen receptor tail clue
2. A 13-amino-acid motif in the cytoplasmic domain of FcγRI-IB modulates B-cell receptor signalling
3. Inhibitory receptors abound?
4. Fc receptor biology
5. The paired Ig-like receptor PIR-B is an inhibitory receptor that recruits the protein-tyrosine phosphatase SHP-1
6. Negative signaling pathways of the killer cell inhibitory receptor and FcγRIIb1 require distinct phosphatases
7. Mouse mast cell gp49B1 contains two immunoreceptor tyrosine-based inhibition motifs and suppresses mast cell activation when coligated with the high-affinity Fc receptor for IgE
8. A monoclonal antibody that inhibits secretion from rat basophilic leukemia cells and binds to a novel membrane component
9. Negative regulation of FcεRI-mediated degranulation by CD81
10. Inhibitory and stimulatory functions of paired Ig-like receptor (PIR) family in RBL-2H3 cells
11. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells
12. High affinity human IgE receptor (FcεRI). Analysis of functional domains of the α-subunit with monoclonal antibodies
13. Generation and use of anti-phosphotyrosine antibodies for immunoblotting
14. Heterogeneity of human IgG Fc receptors
15. Membrane and cytoskeletal changes associated with IgE-mediated serotonin release from rat basophilic leukemia cells
16. Preparation of monoclonal antibodies: Strategies and procedures
17. Purification of human basophils by density and size alone
18. Identification of the FcεRI-activated tyrosine kinases Lyn, Syk, and Zap-70 in human basophils
19. Dissociation of IgE from receptors on human basophils. I. Enhanced passive sensitization for histamine release
20. Expression of functional CD32 molecules on human NK cells is determined by an allelic polymorphism of the FcγRIIC gene
21. 2+ responses of RBL-2H3 mast cells
22. Inhibition of mast cell FcεRI-mediated signaling and effector function by the Syk-selective inhibitor, piceatannol
23. Expression of protein kinase C isozymes in human basophils: Regulation by physiological and nonphysiological stimuli
24. Differential association of phosphatases with hematopoietic co-receptors bearing immunoreceptor tyrosine-based inhibition motifs
25. The same tyrosine-based inhibition motif, in the intracytoplasmic domain of FcγRIIB, regulates negatively BCR-, TCR-, and FcR-dependent cell activation
26. Regulation of high-affinity IgE receptor-mediated mast cell activation by murine low-affinity IgG receptors
27. Demonstration of Fcγ receptors on human basophil granulocytes
28. Human basophils selectively express the FcγRII (CDw32) subtype of IgG receptor
29. Further characterization of surface membrane structures expressed on human basophils and mast cells
30. Signal transduction and cytokine production by human basophils
31. Co-ligation of the antigen and Fc receptors gives rise to the selective modulation of intracellular signaling in B cells. Regulation of the association of phosphatidylinositol 3-kinase and inositol 5'-phosphatase with the antigen receptor complex
32. 2+ mobilization is integrated by CD19 dephosphorylation
33. Deletion of SHIP or SHP-1 reveals two distinct pathways for inhibitory signaling
34. Tyrosine-containing sequence motifs of the human immunoglobulin G receptors FcγRIIb1 and FcγRIIb2 essential for endocytosis and regulation of calcium flux in B cells
35. Fcε RI-mediated tyrosine phosphorylation and activation of the 72-kDa protein-tyrosine kinase, PTK72, in RBL-2H3 rat tumor mast cells
36. Protein-tyrosine kinase p72syk in high affinity IgE receptor signaling. Identification as a component of pp72 and association with the receptor gamma chain after receptor aggregation
37. Syk deficiency in non-releaser basophils
38. Fcε receptor I-associated lyn-dependent phosphorylation of Fcγ receptor IIB during negative regulation of mast cell activation
39. The emerging field of receptor-mediated inhibitory signaling: SHP or SHIP?
40. Selective in vivo recruitment of the phosphatidylinositol phosphatase SHIP by phosphorylated FcγRIIB during negative regulation of IgE-dependent mouse mast cell activation
41. gp49B1 inhibits IgE-initiated mast cell activation through both immunoreceptor tyrosine-based inhibitory motifs, recruitment of src homology 2 domain-containing phosphatase-1, and suppression of early and late calcium mobilization
42. The src homology 2-containing inositol phosphatase (SHIP) is the gatekeeper of mast cell degranulation
43. CD22 associates with protein tyrosine phosphatase 1C, Syk, and phospholipase C-γ1 upon B cell activation
44. Recruitment and activation of PTP1C in negative regulation of antigen receptor signaling by FcγRIIB1
45. Requirement of SH2-containing protein tyrosine phosphatases SHP-1 and SHP-2 for paired immunoglobulin-like receptor B (PIR-B)-mediated inhibitory signal
46. Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B
47. Expression of dominant-negative Src-homology domain 2-containing protein tyrosine phosphatase-1 results in increased Syk tyrosine kinase activity and B cell activation
48. CD5 negatively regulates the T-cell antigen receptor signal transduction pathway: Involvement of SH2-containing phosphotyrosine phosphatase SHP-1
49. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals
50. Direct association with and dephosphorylation of Jak2 kinase by the SH2-domain-containing protein tyrosine phosphatase SHP-1
51. Direct regulation of ZAP-70 by SHP-1 in T cell antigen receptor signaling